Clinical Trial

Microbiome Alterations With Xylitol (MAX) in Pregnancy

Study acronym: MAX
Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to understand if chewing xylitol-gum initiated before 20 weeks of pregnancy and continued until delivery affects the bacteria that are found in the oral and vaginal cavities, signs of inflammation within the gingiva of the oral cavity, the health of the tissues in the mouth (clinical parameters of periodontal disease) and placentae, and the bacteria in the mouth and gut of newborns among pregnant individuals in Malawi. In addition, we will evaluate the impact of xylitol-containing chewing gum use during pregnancy on the offsprings neurodevelopment at approximately 6- and 18-months corrected age.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-03-25; most recent amendment 2026-03-06.
Status change: Recruiting → Active, Not Recruiting 2025-09-05
Status change: Not Yet Recruiting → Recruiting 2024-06-27
Trial Details
NCT Number NCT06329596
Lead Sponsor Baylor College of Medicine
Collaborators: Fogarty International Center of the National Institute of Health, University of Washington, Baylor College of Medicine Children's Foundation, Thrasher Medical Research Foundation, Cure Within Reach
Conditions Dysbiosis, Inflammation Gum, Placenta-mediated Pregnancy Complications, Microbioata, Neurodevelopmental Changes (Childhood, Ageing)
Enrollment 80 participants
Start Date 2024-06-13
Primary Completion 2027-08-20 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-10